Core G: Genetics & High Throughput Omics
Core G: Genetics & High Throughput Omics
批准号:
10164701
负责人:
Carlos Cruchaga
金额:
$27.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-15 至 2025-04-30
关键词:
AgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmyloid beta-ProteinAmyloid beta-Protein PrecursorAutopsyBiocompatible MaterialsBioinformaticsBiological MarkersBiological databasesBiologyBiopsyBloodBlood specimenBrainC9ORF72CharacteristicsClinicalCommunitiesComplexDNADNA LibraryDataData AnalysesDatabasesDementiaDepositionDeveloped CountriesDiseaseFaceFamilyFamily PhysiciansFrontotemporal DementiaGenesGeneticGenetic DiseasesGenetic studyGenomicsGenotypeGoalsIndividualIntentionLeadMAPT geneMolecular ProfilingMultiomic DataMutationNeurodegenerative DisordersParietal LobeParticipantPhenotypePlasmaPopulationProcessProteomicsRNAResearchResearch PersonnelSalivaSamplingShipsTissuesbiobankbrain tissuedata managementdata sharingdisorder riskexome sequencingfunctional genomicsgenetic informationgenetic risk factorgenome sequencinggenome wide association studygranulininterestkindredmolecular markerneuropathologynew therapeutic targetnovelnovel markerpolygenic risk scorepresenilin-1presenilin-2protein aggregationprotein misfoldingrecruitrepositoryrisk prediction modelstatisticstau Proteinstranscriptome sequencingtranscriptomicswhole genome
中文摘要
核心G:遗传学和高通量-OMICS项目摘要
世界各地的老龄化人口,特别是发达国家的老龄化人口,面临着日益沉重的
神经退行性疾病,特别是阿尔茨海默病(AD)、额颞叶痴呆(FTD)和其他
AD相关痴呆(ADRD)。基因研究极大地促进了我们对这些的理解。
复杂的疾病。对孟德尔型阿尔茨海默病的初步研究发现,
编码β-淀粉样前体蛋白(APP)、早老素1(PSEN1)和早老素2(PSEN2)的基因。
已发现颗粒蛋白(GRN)、微管相关蛋白Tau(MAPT)和C9orf72基因突变
作为FTD的原因。这些疾病的特点是蛋白质错误折叠和聚集,也有
一些临床和神经病理特征。二十一世纪的承诺是我们将成为
能够根据遗传原因或遗传风险因素对这些疾病进行分类。此外,很明显,研究
除了遗传学之外,还需要转录组学、蛋白质组学或表观组学来充分理解
AD和ADRDS的生物学,目的是确定新的生物标记物和治疗靶点。目标是
Knight ADRC的Genetics和High Throughout-Omics核心是获取、银行和QC
来自骑士ADRC参与者的生物标本(DNA、RNA和血浆)。核心共享这些生物群落
有资格的调查人员将为这些样本产生基因或其他基因组数据。核心也是
存储和协调所有全基因组关联研究(GWAS)、全外显子组测序(WES)、
为骑士ADRC参与者生成的基因组测序(WGS)、转录和蛋白质组数据
以保证数据的完整性和兼容性,以便这些数据可以与科学工作者共享
社区。
英文摘要
Core G: Genetics and High Throughput -Omics Project Summary
Aging populations worldwide, particularly in developed countries, face an increasing burden of
neurodegenerative diseases, particularly Alzheimer disease (AD), Frontotemporal dementia (FTD), and other
AD-related dementias (ADRDs). Genetic studies have greatly contributed to our understanding of these
complex diseases. Initial studies of a Mendelian form of AD resulted in the identification of mutations in the
genes encoding β-amyloid precursor protein (APP), Presenilin 1 (PSEN1), and Presenilin 2 (PSEN2).
Mutations in Granulin (GRN), Microtubule-Associated Protein Tau (MAPT), and C9orf72 have been identified
as causes of FTD. These diseases are characterized by protein misfolding and aggregation, and also share
some clinical and neuropathological characteristics. The promise of the twenty-first century is that we will be
able to classify these diseases by the genetic cause or genetic risk factors. Furthermore, it is clear that studies
beyond genetics, such as transcriptomics, proteomics, or epigegomics, are needed to fully understand the
biology of AD and ADRDs, with the intention of identifying novel biomarkers and therapeutic targets. The goal
of the Genetics and High Throughput -Omics Core at the Knight ADRC is to obtain, bank and QC
biospecimens (DNA, RNA and plasma) from Knight ADRC participants. The Core shares these biospecimens
with qualified investigators that will generate genetic or other -omic data for these samples. The Core also
stores and harmonizes all genome-wide association study (GWAS), whole exome sequencing (WES), whole
genome sequencing (WGS), transcriptomic, and proteomic data generated for Knight ADRC participants in
order to guarantee the integrity and compatibility of the data so that these data can be shared with the scientific
community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetics Core
-
批准号:10629118
-
项目类别:
-
资助金额:$27.26万
-
财政年份:2023
-
负责人:Carlos Cruchaga
-
依托单位:
Multimodal Characterization of the Role of Circular RNAs in Alzheimer's Disease
-
批准号:10446362
-
项目类别:
-
资助金额:$226.52万
-
财政年份:2022
-
负责人:Carlos Cruchaga
-
依托单位:
Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging
-
批准号:10518934
-
项目类别:
-
资助金额:$184.62万
-
财政年份:2022
-
负责人:Carlos Cruchaga
-
依托单位:
Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging
-
批准号:10677894
-
项目类别:
-
资助金额:$180.99万
-
财政年份:2022
-
负责人:Carlos Cruchaga
-
依托单位:
Genetic Architecture of Alzheimer’s disease Proteinopathies
-
批准号:9995650
-
项目类别:
-
资助金额:$224.33万
-
财政年份:2021
-
负责人:Carlos Cruchaga
-
依托单位:
Genetic Architecture of Alzheimer’s disease Proteinopathies
-
批准号:10391426
-
项目类别:
-
资助金额:$210.2万
-
财政年份:2021
-
负责人:Carlos Cruchaga
-
依托单位:
THE GENETICS AND MULTI-OMICS SPECIMENS CORE (GMSC)
-
批准号:10283067
-
项目类别:
-
资助金额:$72.92万
-
财政年份:2021
-
负责人:Carlos Cruchaga
-
依托单位:
THE GENETICS AND MULTI-OMICS SPECIMENS CORE (GMSC)
-
批准号:10673899
-
项目类别:
-
资助金额:$71.63万
-
财政年份:2021
-
负责人:Carlos Cruchaga
-
依托单位:
Genetic Architecture of Alzheimer’s disease Proteinopathies
-
批准号:10581599
-
项目类别:
-
资助金额:$189.59万
-
财政年份:2021
-
负责人:Carlos Cruchaga
-
依托单位:
Brain Single-nuclei and iPS-derived cells transcriptomic analysis to define the contribution of neuronal and glial pathw
-
批准号:10302162
-
项目类别:
-
资助金额:$71.91万
-
财政年份:2021
-
负责人:Carlos Cruchaga
-
依托单位:
Genetic Architecture of Alzheimer’s disease Proteinopathies
-
批准号:10532581
-
项目类别:
-
资助金额:$31.78万
-
财政年份:2021
-
负责人:Carlos Cruchaga
-
依托单位:
Core G: Genetics & High Throughput Omics
-
批准号:10622644
-
项目类别:
-
资助金额:$53.99万
-
财政年份:2020
-
负责人:Carlos Cruchaga
-
依托单位:
The Familial Alzheimer Sequencing (FASe) Project
-
批准号:10470727
-
项目类别:
-
资助金额:$66.98万
-
财政年份:2018
-
负责人:Carlos Cruchaga
-
依托单位:
The Familial Alzheimer Sequencing (FASe) Project
-
批准号:9753083
-
项目类别:
-
资助金额:$69.94万
-
财政年份:2018
-
负责人:Carlos Cruchaga
-
依托单位:
The Familial Alzheimer Sequencing (FASe) Project
-
批准号:9980750
-
项目类别:
-
资助金额:$76.7万
-
财政年份:2018
-
负责人:Carlos Cruchaga
-
依托单位:
The Familial Alzheimer Sequencing (FASe) Project
-
批准号:10228578
-
项目类别:
-
资助金额:$68.87万
-
财政年份:2018
-
负责人:Carlos Cruchaga
-
依托单位:
Identification and characterization of AD risk networks using multi-dimensional "omics" data
-
批准号:9816679
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2016
-
负责人:Carlos Cruchaga
-
依托单位:
Identification and characterization of AD risk networks using multi-dimensional "omics" data
-
批准号:9755309
-
项目类别:
-
资助金额:$76.22万
-
财政年份:2016
-
负责人:Carlos Cruchaga
-
依托单位:
Core G: Genetics
-
批准号:9066558
-
项目类别:
-
资助金额:$18.07万
-
财政年份:2016
-
负责人:Carlos Cruchaga
-
依托单位:
Genetic Architecture of Acute Human Brain Ischemia
-
批准号:8704525
-
项目类别:
-
资助金额:$60.09万
-
财政年份:2014
-
负责人:Carlos Cruchaga
-
依托单位: